From ENT care to oncology, the companies in this session are redefining how medicine is practiced, delivered, and experienced. Whether through novel device engineering, AI-powered diagnostics, or breakthrough therapeutics, these […]
This session showcases software companies using artificial intelligence, automation, and modern cloud platforms to solve real-world problems across healthcare, construction, education, finance, and beyond. What unites them is a commitment […]
In addition to the DPAC Stage presentations, Venture Connect features a dynamic lightning round where emerging life science companies present rapid-fire pitches.
We are excited to host an invite-only Biotech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow biotech investors over lunch and engage in insightful […]
Take a break, grab a bite, and connect organically with fellow attendees. This unscripted, unstructured lunch is your time to step outside, spark new conversations, and build relationships in a […]
The companies in this session are confronting some of the most pressing environmental and agricultural challenges of our time. From climate-resilient crops to next-generation water treatment and sustainable seafood, these […]
Transaction readiness isn’t a last-minute sprint—it’s the result of disciplined decisions made years earlier. In this session, Tyson Nargassans, CED Founder in Residence and CEO of Slope Software, shares hard-won […]
Boards can accelerate your company or slow it down. In this interactive workshop, Mitch Heath draws on his experience leading and scaling a venture backed company to tackle real boardroom […]
The companies in this session are operating at the frontier of what hardware and deep technology can do. From advanced robotics and satellite systems to novel materials and semiconductor architecture, […]
An informal, high-energy meet-up designed to connect students, startups, and university partners in one room. Whether you're a founder looking for sharp summer talent or a student seeking a hands-on […]
Join a respected panel of growth-stage investors (moderated by Peter Franconi of Fulcrum Equity Partners) as they discuss relevant topics ranging from the capital raising environment to the prevalence of […]
Given the long roadmaps, most life science companies are going to exit well before revenue and some exit much earlier than originally planned. How did these opportunities unfold? How did […]